SCHEMBL6598236

SCHEMBL6598236

COc1cc(Nc2ncnc(-c3cccnc3Nc3cccc(CC=O)c3)n2)cc(OC)c1OC

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 2/20 0.73
KDR P35968 1/20 0.62
FGFR3 P22607 10/20 0.55
FGFR2 P21802 9/20 0.55
CCNT1 O60563 4/20 0.51
CCNE1 P24864 4/20 0.51
CDK2 P24941 4/20 0.51
CDK9 P50750 4/20 0.51
CCNE2 O96020 2/20 0.51
CCNK O75909 1/20 0.51
CDK1 P06493 1/20 0.51
YES1 P07947 1/20 0.51
LYN P07948 1/20 0.51
FGR P09769 1/20 0.51
SRC P12931 1/20 0.51
CCNB1 P14635 1/20 0.51
CCNA2 P20248 1/20 0.51
EPHA1 P21709 1/20 0.51
ABL2 P42684 1/20 0.51
GSK3A P49840 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14214549 0.84 TEK (0.77) TEKKDRFGFR3FGFR2CCNT1
SCHEMBL6480366 0.84 TEK (0.76) TEKKDRFGFR3FGFR2PTK2
SCHEMBL6492448 0.83 TEK (0.75) TEKKDRFGFR3FGFR2PTK2
SCHEMBL14214554 0.83 TEK (0.74) TEKKDRFGFR3FGFR2PTK2
SCHEMBL14214739 0.82 TEK (0.82) TEKKDRFGFR3FGFR2PTK2
SCHEMBL6478685 0.82 TEK (0.76) TEKKDRFGFR3FGFR2PTK2
SCHEMBL14214552 0.81 TEK (0.81) TEKKDRFGFR3FGFR2FGFR1
SCHEMBL6479686 0.81 TEK (0.89) TEKKDRFGFR3FGFR2PTK2
SCHEMBL6480986 0.80 TEK (0.74) TEKKDRFGFR3FGFR2PTK2
SCHEMBL6486793 0.78 TEK (0.82) TEKKDRFGFR3FGFR2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed